June Off to a Poor ...
Health Care: Drugs
AMAG Pharmaceuticals Inc. (AMAG: NASDAQ)
$13.58 -0.45 | -3.21%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 13.58 |
| 52 Week High | 19.62 |
| 52 Week Low | 12.43 |
| Avg. Daily Vol. (Mil) | 0.14 |
| Beta (3 year) | -0.36 |
| Share Related Items | |
| Mkt Cap (Mil) | 290.05 |
| Shares Out (Mil) | 21.36 |
| Float (Mil) | 14.46 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.50 |
| Current Ratio | 6.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.58 |
| Price/Book | 1.71 |
| Price/Cash Flow | -4.70 |
| Per Share Data | |
| Earnings | -3.16 |
| Sales | 2.97 |
| Book Value | 7.96 |
| Cash Flow | -2.87 |
| Business Summary | |
|---|---|
| A biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. | |
| General Information | |
| 100 Hayden Avenue
Lexington, MA 02421 |
|
| www.amagpharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 174 | |
| CEO: Mr. Frank E. Thomas | |
| Short Interest | |
| Current Month (Mil) | 1.11 |
| Previous Month (Mil) | 1.03 |
| Short Interest Ratio (Days) | 6.50 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -26.50 |
| Return on Investments | -39.00 |
| Profitability | |
| Gross Margin | 93.40 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with AMAG
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- UserPelican Watch
- UserPART 1 JPMorgan 28th Annual...
- UserPART 1 JPMorgan 27th Annual...
- Userileana
- UserShawen Portfolio 1
- Userfiallo Portfolio 1
- UserTSimao Portfolio 1
- Usersggrimsley
Latest AMAG Headlines from TheStreet
- 8 Stocks Rising on Huge Volume 04.20.12 | 01:04 pm
- Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail 03.09.12 | 05:03 am
- Insiders Trading AMAG, CLWR, GTXI 03.06.12 | 10:03 am
- More Biotech Lessons Learned From JPM 2012 01.13.12 | 06:01 am
- The Next Big Thing In Biotech: 2012 Outlook
01.06.12 | 05:01 am - 5 Stocks Poised for Breakouts 11.07.11 | 09:11 am
- Next Step for Amag's Board: Fire CEO, Sell the Company. 10.21.11 | 11:10 am
- Biotech Stock Mailbag: Keryx Pharma 10.14.11 | 06:10 am
- Activist Fund Manager Ups Stake in Amag Pharma to Stop Merger With Allos 10.10.11 | 10:10 am
- Spectrum Pharma Said to Make Bid for Allos 09.21.11 | 11:09 am
Press Releases for AMAG
- AMAG Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences - Business Wire 05.29.12 | 05:05 pm
- AMAG Pharmaceuticals Appoints William Heiden As President And Chief Executive Officer - Business Wire 05.09.12 | 04:05 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On May 1, 2012 At 4:30 P.m. ET To Discuss Financial Results For The Quarter Ended March 31, 2012 - Business Wire 04.24.12 | 04:04 pm
- AMAG Pharmaceuticals Announces A Positive CHMP Opinion For The Approval Of Ferumoxytol In Europe For The Treatment Of Iron Deficiency Anemia In Adult Patients With Chronic Kidney Disease - Business Wire 04.20.12 | 09:04 am
- AMAG Pharmaceuticals Announces Preliminary Results From Its Phase III Study Evaluating Feraheme Compared To IV Iron Sucrose In Patients With Iron Deficiency Anemia - Business Wire 03.07.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On March 7, 2012 At 4:30 P.m. ET To Discuss Feraheme Clinical Trial Results - Business Wire 03.06.12 | 04:03 pm
- AMAG Announces Fourth Quarter And Year End 2011 Financial Results - Business Wire 03.05.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Present At The 24th Annual ROTH Conference - Business Wire 03.02.12 | 04:03 pm
- AMAG Pharmaceuticals, Inc. To Host Conference Call On March 5, 2012 At 4:30 P.m. ET To Discuss Financial Results For The Fourth Quarter And Year Ended 2011 - Business Wire 02.23.12 | 04:02 pm
- AMAG Pharmaceuticals, Inc. To Present At Upcoming Investor Conferences - Business Wire 02.13.12 | 04:02 pm
Partner Headlines for AMAG
- AMAG Beats Riding on Feraheme Sales - Analyst Blog - Zacks 05.02.12 | 10:05 am
- AMAG Pharmaceuticals Reports Mixed Q4 Results - Benzinga 03.05.12 | 04:03 pm
- AMAG Pharmaceuticals Reports Mixed Q4 Results - Benzinga 03.05.12 | 04:03 pm
- Israel Englander's Stock Picks With Insider Purchases - Seeking Alpha 01.18.12 | 09:01 am
- 17 Breakout Stocks Boosted By Insiders - Seeking Alpha 12.30.11 | 04:12 pm
- McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23 - Benzinga 12.12.11 | 01:12 pm
- Mid-Day Update: Stocks Pare Some Early Losses; Unemployment Claims Lift Sentiment - NASDAQ 11.17.11 | 05:11 pm
- Loss Shrinks at AMAG, CEO Departs - Analyst Blog - Zacks 11.08.11 | 10:11 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 10.26.11 | 09:10 am
- Stocks Rally on European Debt Summit Optimism; December Crude Surges Over 2% - NASDAQ 10.21.11 | 04:10 pm
